Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02QBV
|
|||
| Former ID |
DNC013320
|
|||
| Drug Name |
N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide
|
|||
| Synonyms |
CHEMBL231583; N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide; SCHEMBL963386
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H17FN2O2
|
|||
| Canonical SMILES |
C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CNCC(=O)N
|
|||
| InChI |
1S/C16H17FN2O2/c17-14-3-1-2-13(8-14)11-21-15-6-4-12(5-7-15)9-19-10-16(18)20/h1-8,19H,9-11H2,(H2,18,20)
|
|||
| InChIKey |
UZDHMFDYNZICFG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.